Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
847.00    -9.00 (-1.05%)
Bid:
836.00
Ask:
847.00
Spread: 11.00 (1.316%)
Market Cap: £798.98m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding - Replacement

19 Aug 2025 11:08

RNS Number : 9183V
Polar Capital Holdings PLC
19 August 2025
 

19 August 2025

 

The following amendments have been made to the Director/PDMR Shareholding announcement released on 15 August 2025 at 9:42am under RNS No 5227V.

 

The prices have been amended.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Polar Capital Holdings plc ("Polar Capital" or the "Company")

 

Notification of Transactions by Persons Discharging Managerial Responsibilities (PDMRs)/Persons Closely Associated (PCAs)

 

The Company was notified on 13 August 2025 that Ms. Rachel Stynes purchased 1,801 ordinary shares of 2.5p each ("Ordinary Shares") following an automatic dividend reinvestment for her personal holding at an aggregated price of 486.55p per share. Following this transaction Ms. Stynes is interested in a total of 32,033 Ordinary Shares representing 0.03% of the Company's issued share capital.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Rachel Stynes

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Human Resources

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Polar Capital Holdings plc

b)

 

LEI

 

549300OXX7YE1947B825

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5p each

Identification code

GB00B1GCLT25

b)

 

Nature of the transaction

 

Acquisition following dividend reinvestment

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

487.59 pence per share

980

485.50 pence per share

821

d)

 

Aggregated information

as in 4 c) above

- Aggregated volume

1801

- Price

486.55 pence per share

 

e)

 

Date of the transaction

 

13/08/2025

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Polar Capital +44 (0)20 7227 2700

Gavin Rochussen (Chief Executive)

Samir Ayub (CFO)

 

Deutsche Numis - Nomad and Joint Broker +44 (0)20 7260 1000

Giles Rolls (QE)

Charles Farquhar

 

Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680

Andrew Buchanan

Sam Milford

 

Camarco +44 (0)20 7757 4995

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEPNFELSEFA
Date   Source Headline
19th Mar 20194:42 pmRNSDirector/PDMR Shareholding
15th Mar 20194:28 pmRNSIssue of Equity
14th Mar 201912:08 pmRNSBlock Listing Application
13th Mar 20196:03 pmRNSForm 8.3 - Charter Court Financial Services Group
13th Mar 20194:18 pmRNSForm 8.3 - OneSavings Bank PLC
13th Mar 20194:09 pmRNSForm 8.3 - Charter Court Financial Services Group
1st Mar 20197:00 amRNSTotal Voting Rights
27th Feb 201910:00 amRNSIssue of Equity
20th Feb 20194:54 pmRNSIssue of Equity
18th Feb 201911:09 amRNSHolding(s) in Company
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.